Bridgepoint Group plc has agreed to acquire Kayne Anderson Real Estate from Kayne Anderson Capital Advisors for an upfront enterprise value of approximately $1.39 billion. The consideration will consist of $759 million in cash alongside approximately 189 million new Bridgepoint ordinary shares.
Kayne Anderson Real Estate is a Boca Raton, Florida-headquartered platform managing $22 billion in assets across both real estate equity and debt strategies. Its investment focus spans multiple alternative real estate sectors, including medical office, seniors housing, student housing, multifamily housing and light industrial properties across the United States.
Under the terms of the transaction the combined business will represent about $117 billion of assets under management across five verticals: private equity at $40 billion, credit at $21 billion, infrastructure at $30 billion, real estate at $22 billion and secondaries at $4 billion. Bridgepoint said the acquisition will push US-domiciled management fee contribution from 28% to 42% for the enlarged group.
Bridgepoint also quantified the expected change in revenue mix. Fee-related earnings are projected to account for roughly 60% of EBITDA for the combined entity, compared with about 50% for Bridgepoint on a standalone basis.
Operationally and on fund-raising metrics, Kayne Anderson Real Estate has shown rapid expansion. Its most recent flagship vehicle, KAREP VII, closed on May 15, 2026 with $5.12 billion of commitments - nearly twice the size of its predecessor - and the platform has grown at an approximate 20% annual rate between 2019 and May 2026.
Bridgepoint provided forward-looking financial impacts tied to the deal. The group expects the acquisition to be earnings per share accretive, increasing Bridgepoint’s EPS by a mid-single-digit percentage in 2027 and by more than 20% in 2028. The purchase price equates to a high single-digit multiple of expected 2027 EBITDA for Kayne Anderson Real Estate, which Bridgepoint estimated would reduce to a mid-single-digit multiple in 2028.
Additional consideration may be payable in shares. Up to 102.5 million further Bridgepoint shares could be issued in 2030 if certain management fee-related performance hurdles are met.
Quoted reactions from senior executives accompanied the announcement. Raoul Hughes, Bridgepoint’s Chief Executive, said: "This marks another major step forward in our strategy to strengthen our position as a leading global middle-market private markets platform. Real estate is a growing private markets asset class and Kayne Anderson Real Estate has built a leading position as a scaled specialist with an exceptional track record and strong fundraising momentum."
From Kayne Anderson Real Estate, Co-Founder and Chief Executive Officer Al Rabil commented: "For the last 20 years, we have built a scaled real estate platform focused on mission-critical alternative sectors where we believe long-term fundamental tailwinds and operational complexity create compelling investment opportunities." The management team led by Rabil and Chief Investment Officer David Selznick will continue to run the business under the Kayne Bridgepoint brand.
The parties expect the transaction to complete by the end of 2026, subject to shareholder approval, regulatory approvals and fund consents. Bridgepoint stated the cash portion of the purchase will be funded from its existing balance sheet resources and available credit facilities.
Alongside the transaction disclosure, Bridgepoint adjusted its standalone outlook. The company now expects EBITDA for the twelve-month period ending December 31, 2027 to be between A3390 million and A3460 million. It also raised its fundraising guidance for 2024-2026 to A328 billion.
Summary
Bridgepoint will acquire Kayne Anderson Real Estate for about $1.39 billion in a deal combining cash and newly issued shares, bringing a $22 billion real estate platform into a combined vehicle managing roughly $117 billion. The acquisition is projected to raise the US share of management fees, shift EBITDA mix toward fee-related earnings, and be accretive to EPS in both 2027 and 2028. Completion is expected by the end of 2026 and remains subject to customary approvals and consents.
Key points
- Transaction structure and size - $759 million cash plus about 189 million new Bridgepoint shares, with up to 102.5 million additional shares contingent on performance hurdles in 2030.
- Strategic scale and sector exposure - adds a $22 billion real estate platform focused on medical office, seniors housing, student housing, multifamily and light industrial; expands combined AUM to about $117 billion across five private markets verticals.
- Financial impact - increases US-domiciled management fee contribution from 28% to 42%; fee-related earnings expected to be about 60% of combined EBITDA; EPS accretive in 2027 (mid-single-digit uplift) and significantly accretive in 2028 (more than 20%).
Risks and uncertainties
- Regulatory and approval risk - the deal is conditioned on shareholder approval, regulatory approvals and fund consents ahead of an expected close at the end of 2026.
- Performance hurdle for earn-out - up to 102.5 million additional Bridgepoint shares are contingent on management fee-related performance metrics to 2030.
- Funding and execution - the cash consideration will be sourced from Bridgepoint E2 80 99s balance sheet resources and available credit facilities, which introduces execution risk tied to financing and integration.